Top

Alzheimer's Research & Therapy

Published in:

Open Access 01-12-2016 | Research

Brain perfusion in dementia with Lewy bodies and Alzheimer’s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages

Authors: Daniel Roquet, Marion Sourty, Anne Botzung, Jean-Paul Armspach, Frédéric Blanc

Published in: Alzheimer's Research & Therapy | Issue 1/2016

Abstract

Background

We aimed to describe specific changes in brain perfusion in patients with dementia with Lewy bodies (DLB) at both the prodromal (also called mild cognitive impairment) and mild dementia stages, relative to patients with Alzheimer’s disease (AD) and controls.

Methods

Altogether, 96 participants in five groups (prodromal DLB, prodromal AD, DLB with mild dementia, AD with mild dementia, and healthy elderly controls) took part in an arterial spin labeling MRI study. Three analyses were performed: a global perfusion value comparison, a voxel-wise analysis of both absolute and relative perfusion, and a linear discriminant analysis. These were used to assess the global decrease in perfusion, regional changes, and the sensitivity and specificity of these changes.

Results

Patterns of perfusion in DLB differed from AD and controls in both the prodromal stage and dementia, DLB having more deficits in frontal, insular, and temporal cortices whereas AD showed reduced perfusion in parietal and parietotemporal cortices. Decreases but also increases of perfusion in DLB relative to controls were observed in both absolute and relative measurements. All these regional changes of perfusion classified DLB patients with respect to either healthy controls or AD with sensitivity from 87 to 100 % and specificity from 90 to 96 % depending on the stage of the disease.

Conclusions

Our results are consistent with previous studies. We extend the scope of those studies by integrating prodromal DLB patients and by describing both hypo- and hyperperfusion in DLB. While decreases in perfusion may relate to functional impairments, increases might suggest a functional compensation of some brain areas.

Available only for authorised users

McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005; 65(12):1863–72. doi:http://dx.doi.org/10.1212/01.wnl.0000187889.17253.b1.CrossRefPubMed

Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013; 81(23):2032–8.CrossRefPubMedPubMedCentral

Nelson PT, Jicha Ga, Kryscio RJ, Abner EL, Schmitt Fa, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol. 2010; 257(3):359–66. doi:http://dx.doi.org/10.1007/s00415-009-5324-y.CrossRefPubMed

Mega M, Masterman D, Benson D. Dementia with Lewy bodies reliability and validity of clinical and pathologic criteria. Neurology. 1996; 47(6):1403–9.CrossRefPubMed

Richards M, Marder K. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol. 1991; 48(11):1147–9.CrossRefPubMed

Lee DR, McKeith I, Mosimann U, Ghosh-Nodial A, Grayson L, Wilson B, et al. The dementia cognitive fluctuation scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia. Am J Geriatr Psychiatr. 2014; 22(9):926–35. doi:http://dx.doi.org/10.1016/j.jagp.2013.01.072.CrossRef

Caffarra P, Gardini S, Dieci F, Copelli S, Maset L, Concari L, et al. The qualitative scoring MMSE pentagon test (QSPT): a new method for differentiating dementia with Lewy body from Alzheimer’s disease. Behav Neurol. 2013; 27(2):213–20. doi:http://dx.doi.org/10.3233/BEN-120319.CrossRefPubMed

Menendez-Gonzalez M, Calatayud MT, Blazquez-Menes B. Exacerbation of Lewy bodies dementia due to memantine. J Alzheimer’s Dis. 2005; 8(3):289–91. doi:http://dx.doi.org/DLB-Converted%2395.

McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992; 305(September):673–8.CrossRefPubMedPubMedCentral

10.

Mak E, Su L, Williams G, O’Brien J. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther. 2014; 6(2):18.CrossRefPubMedPubMedCentral

11.

Goto H, Ishii K, Uemura T, Miyamoto N, Yoshikawa T, Shimada K, et al. Differential diagnosis of dementia with Lewy bodies and Alzheimer disease using combined MR imaging and brain perfusion single-photon emission tomography. Am J Neuroradiol. 2010; 31(4):720–5. doi:http://dx.doi.org/10.3174/ajnr.A1926.CrossRefPubMed

12.

Hanyu H, Shimizu S, Hirao K, Kanetaka H, Sakurai H, Iwamoto T, et al. Differentiation of dementia with Lewy bodies from Alzheimer’s disease using Mini-Mental State Examination and brain perfusion SPECT. J Neurol Sci. 2006; 250(1–2):97–102. doi:http://dx.doi.org/10.1016/j.jns.2006.07.007.CrossRefPubMed

13.

Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, et al. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging. 2002; 29(5):615–22. doi:http://dx.doi.org/10.1007/s00259-002-0778-5.CrossRefPubMed

14.

Pasquier J, Michel BF, Brenot-Rossi I, Hassan-Sebbag N, Sauvan R, Gastaut JL. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2002; 29(10):1342–8. doi:http://dx.doi.org/10.1007/s00259-002-0919-x.CrossRefPubMed

15.

Lobotesis K, Fenwick J, Phipps A, Ryman A, Swann A, Ballard C, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 2001; 56(5):643–9.CrossRefPubMed

16.

Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology. 1999; 53(2):413–6.CrossRefPubMed

17.

Takahashi R, Ishii K, Shimada K, Ohkawa S, Nishimura Y. Hypoperfusion of the motor cortex associated with parkinsonism in dementia with Lewy bodies. J Neurol Sci. 2010; 288(1–2):88–91. doi:http://dx.doi.org/10.1016/j.jns.2009.09.033.CrossRefPubMed

18.

Binnewijzend Maa, Kuijer JPa, van der Flier. WM, Benedictus MR, Möller CM, Pijnenburg YaL, et al. Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol. 2014; 24(9):2326–33. doi:http://dx.doi.org/10.1007/s00330-014-3172-3.CrossRefPubMed

19.

Taylor JP, Firbank MJ, He J, Barnett N, Pearce S, Livingstone A. Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. Br J Psychiatry J Ment Sci. 2012; 200(6):491–8. doi:http://dx.doi.org/10.1192/bjp.bp.111.099432.CrossRef

20.

Fong T, Inouye S, Dai W, Press D, Alsop D. Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?Brain Imaging Behav. 2011; 5(1):25–35. doi:http://dx.doi.org/10.1007/s11682-010-9108-x.Association.CrossRefPubMedPubMedCentral

21.

O’Brien JT, Firbank MJ, Davison C, Barnett N, Bamford C, Donaldson C, et al. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias. J Nucl Med. 2014; 55(12):1959–65. doi:http://dx.doi.org/10.2967/jnumed.114.143347.CrossRefPubMed

22.

Spehl TS, Hellwig S, Amtage F, Weiller C, Bormann T, Weber WA, et al. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer’s disease – a [F-18]-FDG PET study. J Neuroimaging. 2015; 25(2):281–8. doi:http://dx.doi.org/10.1111/jon.12104.CrossRefPubMed

23.

Kantarci K, Lowe V, Boeve B, Weigand S, Senjem M, Przybelski S, et al. Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging. 2012; 33(9):2091–105. doi:http://dx.doi.org/10.1016/j.neurobiolaging.2011.09.024.Multimodality.CrossRefPubMed

24.

Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, et al. Differentiation of Alzheimer’s disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Exp Neurol. 2005; 191 Suppl:95–103. doi:http://dx.doi.org/10.1016/j.expneurol.2004.06.017.CrossRef

25.

Ishii K, Soma T, Kono AK, Sofue K, Miyamoto N, Yoshikawa T, et al. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with Lewy bodies and those with mild Alzheimer’s disease. J Nucl Med. 2007; 48(5):704–11. doi:http://dx.doi.org/10.2967/jnumed.106.035691.CrossRefPubMed

26.

Ishii K, Imamura T, Sasaki M, Yamaji S, Hirono N, Shimomura T, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease. Neurology. 1998; 51(1):125–30.CrossRefPubMed

27.

Imamura T, Ishii K, Sasaki M, Kitagaki H, Yamaji S, Hirono N, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease: a comparative study using positron emission tomography. Neurosci Lett. 1997; 235(1–2):49–52.CrossRefPubMed

28.

Henriksen OM, Larsson HBW, Hansen AE, Grüner JM, Law I, Rostrup E. Estimation of intersubject variability of cerebral blood flow measurements using MRI and positron emission tomography. J Magn Reson Imaging. 2012; 35(6):1290–9. doi:http://dx.doi.org/10.1002/jmri.23579.CrossRefPubMed

29.

The Unified Parkinson’s Disease Rating Scale (UPDRS): Status and recommendations. Mov. Disord. 2003; 18:738–750. doi:http://dx.doi.org/10.1002/mds.10473.

30.

Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, et al. DLB fluctuation. Specific features that reliably differentiate dementia with Lewy bodies from Alzheimer’s disease and normal aging. Neurology. 2004; 62(2):181–7.CrossRefPubMed

31.

Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O’Brien JT, et al. The clinician assessment of fluctuation and the one day fluctuation assessment scale: two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 2000; 177(Sept):252–6. doi:http://dx.doi.org/10.1192/bjp.177.3.252.CrossRefPubMed

32.

Scheltens P, Launer L, Barkhof F, Weinstein H, van Gool W. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995; 242:557–60.CrossRefPubMed

33.

Koedam ELGE, Lehmann M, Van Der Flier WM, Scheltens P, Pijnenburg YAL, Fox N, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011; 21(12):2618–25. doi:http://dx.doi.org/10.1007/s00330-011-2205-4.CrossRefPubMedPubMedCentral

34.

Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for age-related white matter changes. Stroke. 2001; 32:1318–22. doi:http://dx.doi.org/10.1161/01.STR.32.6.1318.CrossRefPubMed

35.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734–46. doi:http://dx.doi.org/10.1016/S1474-4422(07)70178-3.CrossRefPubMed

36.

Petersen RC. Mild cognitive impairment as a diagnostic utility. J Intern Med. 2004; 256:183–94.CrossRefPubMed

37.

Chuang K, Gelderen PV, Merkle H, Bodurka J, Ikonomidou V, Koretsky A, et al. Mapping resting-state functional connectivity using perfusion MRI. Neuroimage. 2008; 40(4):1595–605.CrossRefPubMedPubMedCentral

38.

Foucher JR, Roquet D, Marrer C, Pham BT, Gounot D. Correcting for the echo-time effect after measuring the cerebral blood flow by arterial spin labeling. J Magn Reson Imaging. 2011; 34(4):785–90. doi:http://dx.doi.org/10.1002/jmri.22678.CrossRefPubMed

39.

Preibisch C, Sorg C, Förschler A, Grimmer T, Sax I, Wohlschläger AM, et al. Age-related cerebral perfusion changes in the parietal and temporal lobes measured by pulsed arterial spin labeling. J Magn Reson Imaging. 2011; 34(6):1295–302. doi:http://dx.doi.org/10.1002/jmri.22788.CrossRefPubMed

40.

Liu Y, Zhu X, Feinberg D, Guenther M, Gregori J, Weiner MW, et al. Arterial spin labeling MRI study of age and gender effects on brain perfusion hemodynamics. Magn Reson Medicine Off J Soc Magn Reson Med / Soc Magn Reson Med. 2012; 68(3):912–22. doi:http://dx.doi.org/10.1002/mrm.23286.CrossRef

41.

Yoon JH, Kim M, Moon SY, Yong SW, Hong JM. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment: a 5-year follow-up study. J Neurol Sci. 2015; 355(1–2):174–9. doi:http://dx.doi.org/10.1016/j.jns.2015.06.013.CrossRefPubMed

42.

Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease. Clin Neuropsychol. 2006; 20(4):623–36. doi:http://dx.doi.org/10.1080/13854040500376831.CrossRefPubMed

43.

Mondon K, Gochard A, Marqué A, Armand A, Beauchamp D, Prunier C, et al. Visual recognition memory differentiates dementia with Lewy bodies and Parkinson’s disease dementia. J Neurol Neurosurg Psychiatry. 2007; 78:738–41. doi:http://dx.doi.org/10.1136/jnnp.2006.104257.CrossRefPubMedPubMedCentral

44.

Blanc F, Noblet V, Philippi N, Cretin B, Foucher J, Armspach JP, et al. Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases. PloS ONE. 2014; 9(12):114774. doi:http://dx.doi.org/10.1371/journal.pone.0114774.CrossRef

45.

Heitz C, Noblet V, Cretin B, Philippi N, Kremer L, Stackfleth M, et al. Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimer’s Res Ther. 2015; 7(1):6. doi:http://dx.doi.org/10.1186/s13195-014-0091-0.CrossRef

46.

Cagnin A, Gnoato F, Jelcic N, Favaretto S, Zarantonello G, Ermani M, et al. Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2013; 84(5):505–10. doi:http://dx.doi.org/10.1136/jnnp-2012-304095.CrossRefPubMed

47.

Park D, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol. 2009; 60:173–96. doi:http://dx.doi.org/10.1146/annurev.psych.59.103006.093656.The.CrossRefPubMedPubMedCentral

48.

Persson J, Nyberg L. Altered brain activity in healthy seniors: what does it mean?Prog Brain Res. 2006; 157(06):44–57. doi:http://dx.doi.org/10.1016/S0079-6123(06)57004-9.

49.

Cabeza R, Anderson ND, Locantore JK, McIntosh AR. Aging gracefully: compensatory brain activity in high-performing older adults. NeuroImage. 2002; 17(3):1394–402. doi:http://dx.doi.org/10.1006/nimg.2002.1280.CrossRefPubMed

50.

Binnewijzend MAA, Benedictus MR, Kuijer JPA, van der Flier WM, Teunissen CE, Prins ND, et al. Cerebral perfusion in the predementia stages of Alzheimer’s disease. Eur Radiol. 2016; 26:506–14. doi:http://dx.doi.org/10.1007/s00330-015-3834-9.CrossRefPubMed

51.

Alexopoulos P, Sorg C, Förschler A, Grimmer T, Skokou M, Wohlschläger A, et al. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI. Eur Arch Psychiatry Clin Neurosci. 2012; 262(1):69–77. doi:http://dx.doi.org/10.1007/s00406-011-0226-2.CrossRefPubMed

52.

Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, et al.Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer’s disease among patients with mild cognitive impairment. Neurobiol Aging. 2011; 32(1):15–23. doi:http://dx.doi.org/10.1016/j.neurobiolaging.2009.01.013.CrossRefPubMed

53.

Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord. 2010; 24(1):19–27. doi:http://dx.doi.org/10.1097/WAD.0b013e3181b4f736.ASL.CrossRefPubMedPubMedCentral

54.

Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, et al. Cerebral perfusion correlates of conversion to Alzheimer’s disease in amnestic mild cognitive impairment. J Neurol. 2007; 254(12):1698–707. doi:http://dx.doi.org/10.1007/s00415-007-0631-7.CrossRefPubMed

55.

Chao LL, Pa J, Duarte A, Schuff N, Weiner MW, Kramer JH, et al. Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord. 2009; 23(3):245–52. doi:http://dx.doi.org/10.1097/WAD.0b013e318199ff46.Patterns.CrossRefPubMedPubMedCentral

56.

Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, et al. Brain SPECT in subtypes of mild cognitive impairment: findings from the DESCRIPA multicenter study. J Neurol. 2008; 255(9):1344–53. doi:http://dx.doi.org/10.1007/s00415-008-0897-4.CrossRefPubMed

57.

Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, et al. Resting SPECT–neuropsychology correlation in very mild Alzheimer’s disease. Clin Neurophysiol. 2005; 116(2):364–75. doi:http://dx.doi.org/10.1016/j.clinph.2004.09.001.CrossRefPubMed

58.

Colloby SJ, Taylor JP, Davison CM, Lloyd JJ, Firbank MJ, McKeith IG, et al. Multivariate spatial covariance analysis of SPECT images in dementia with Lewy bodies and AD: utility in differential diagnosis. J Cereb Blood Flow Metab. 2013; 33(4):612–18. doi:http://dx.doi.org/10.1038/jcbfm.2013.2.CrossRefPubMedPubMedCentral

59.

Gevers S, Van Osch MJ, Bokkers RP, Kies DA, Teeuwisse WM, Majoie CB, et al. Intra- and multicenter reproducibility of pulsed, continuous and pseudo-continuous arterial spin labeling methods for measuring cerebral perfusion. J Cereb Blood Flow Metab. 2011; 31(10):1706–15. doi:http://dx.doi.org/10.1038/jcbfm.2011.10.CrossRefPubMedPubMedCentral

Title: Brain perfusion in dementia with Lewy bodies and Alzheimer’s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages
Authors: Daniel Roquet
Marion Sourty
Anne Botzung
Jean-Paul Armspach
Frédéric Blanc
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Alzheimer's Research & Therapy / Issue 1/2016
Electronic ISSN: 1758-9193
DOI: https://doi.org/10.1186/s13195-016-0196-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Brain perfusion in dementia with Lewy bodies and Alzheimer’s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics

Association between dental amalgam fillings and Alzheimer’s disease

Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease

LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

An update on semantic dementia: genetics, imaging, and pathology